The core pathogenic molecules for AD, Aβ42, total tau (t-tau), and p-tau in CSF, were studied beginning in the 1990s and have become reliable and sensitive biomarkers for AD diagnosis [20,21]. The gene discussed is MAPT; the disease is Alzheimer disease.